Compounds > perindopril
Page last updated: 2024-09-02

perindopril and Angiogenesis, Pathologic

perindopril has been researched along with Angiogenesis, Pathologic in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (81.82)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamed, O; Kazem, A; Nasr, M; Selima, E1
Nakka, S; Patel, SS1
Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Mitoro, A; Noguchi, R; Sawai, M; Toyohara, M; Tsujimoto, T; Uemura, M; Yamao, J; Yamazaki, M; Yoshida, M; Yoshiji, H1
Fukui, H; Ikenaka, Y; Imazu, H; Kitade, M; Kuriyama, S; Masaki, T; Mitoro, A; Namisaki, T; Noguchi, R; Tsujinoue, H; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H1
Cao, G; DeRosa, G; Di Gennaro, F; Forcada, P; Toblli, JE1
Ito, A; Komune, S; Kuratomi, Y; Masuda, M; Nakagawa, T; Nakashima, T; Yasumatsu, R1
Ikenaka, Y; Kuriyama, S; Noguchi, R; Yoshii, J; Yoshiji, H1
Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Masaki, T; Namisaki, T; Noguchi, R; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H1
Fukui, H; Ikenaka, Y; Kawata, M; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yoshii, J; Yoshiji, H1
Fukui, H; Kuriyama, S; Yoshiji, H1
Fukui, H; Ikenaka, Y; Imazu, H; Noguchi, R; Tsujinoue, H; Yanase, K; Yoshii, J; Yoshiji, H1

Reviews

1 review(s) available for perindopril and Angiogenesis, Pathologic

ArticleYear
Perindopril: possible use in cancer therapy.
    Anti-cancer drugs, 2002, Volume: 13, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelial Growth Factors; Gene Expression; Humans; Neoplasms; Neovascularization, Pathologic; Perindopril

2002

Trials

1 trial(s) available for perindopril and Angiogenesis, Pathologic

ArticleYear
Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.
    Journal of hepatology, 2009, Volume: 51, Issue:2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Hepatocellular; Catheter Ablation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Perindopril; Survival Rate; Vascular Endothelial Growth Factor A; Vitamin K 2

2009

Other Studies

9 other study(ies) available for perindopril and Angiogenesis, Pathologic

ArticleYear
Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice.
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Antirheumatic Agents; Carcinogens; Carcinoma, Hepatocellular; Curcumin; Diethylnitrosamine; Drug Therapy, Combination; Hypoxia-Inducible Factor 1, alpha Subunit; Isoxazoles; Leflunomide; Liver; Liver Neoplasms; Male; Mice; Neovascularization, Pathologic; Perindopril; Platelet Endothelial Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A

2014
Protective Effect of Perindopril on Tumor Progression and Angiogenesis in Animal Model of Breast Cancer.
    Anti-cancer agents in medicinal chemistry, 2017, Volume: 17, Issue:7

    Topics: Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Animals; Breast; Breast Neoplasms; Chick Embryo; Chickens; Cornea; Disease Models, Animal; Disease Progression; Female; Neovascularization, Pathologic; Perindopril; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A

2017
Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-01, Volume: 9, Issue:16 Pt 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Drug Combinations; Endothelium, Vascular; Humans; Interferon-beta; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Perindopril; Vascular Endothelial Growth Factor A

2003
Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats.
    American journal of hypertension, 2004, Volume: 17, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Disease Models, Animal; Immunohistochemistry; Male; Microvascular Angina; Myocardium; Neovascularization, Pathologic; Obesity; Organ Size; Perindopril; Rats; Rats, Zucker

2004
Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells.
    Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line, Tumor; Female; Head and Neck Neoplasms; Immunoenzyme Techniques; Immunohistochemistry; Indoles; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Perindopril; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A

2004
Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice.
    Oncology reports, 2005, Volume: 13, Issue:3

    Topics: Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Chemoprevention; Drug Therapy, Combination; Interferon-beta; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Perindopril

2005
Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
    Journal of hepatology, 2005, Volume: 42, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antifibrinolytic Agents; Carcinoma, Hepatocellular; Cell Division; Drug Therapy, Combination; Endothelium, Vascular; In Vitro Techniques; Liver; Liver Neoplasms; Male; Neovascularization, Pathologic; Perindopril; Precancerous Conditions; Rats; Rats, Inbred F344; Vitamin K 2

2005
The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:4

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cell Line, Transformed; Disease Models, Animal; Endothelial Growth Factors; Gene Expression; Lymphokines; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Perindopril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2001
Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    International journal of oncology, 2002, Volume: 20, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Movement; Endothelial Growth Factors; Endothelium, Vascular; Liver Neoplasms; Lymphokines; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Perindopril; Renin-Angiotensin System; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002